Albert Khouri, MD, Ophthalmology, Newark, NJ, University Hospital

AlbertSKhouriMD

Ophthalmology Newark, NJ

Cataract Related, Glaucoma Related

Professor of Ophthalmology, Director of Glaucoma & Director of Ophthalmology Residency at Rutgers New Jersey Medical School with offices in Newark, NJ

Dr. Khouri is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Khouri's full profile

Already have an account?

  • Office

    90 Bergen Street
    Doctors Office Center, Suite 6100
    Newark, NJ 07103
    Phone(973) 972-2065
    Fax(973) 972-1244
  • Is this information wrong?

Summary

  • Dr Khouri is faculty at Rutgers University and is an academic glaucoma specialist with offices at the Institute of Ophthalmology and Visual Science at Rutgers New Jersey Medical School in Newark, NJ.
    Dr Khouri specializes in the medical, laser and surgical treatments of glaucoma including Micro-Incisional Glaucoma Surgery (MIGS), and cataract surgery.
    Dr Khouri directs the glaucoma research laboratory at Rutgers and conducts clinical trials for novel medications, drug delivery systems as well as innovations in imaging and diagnostics in glaucoma and the field of telemedicine and teleglaucoma.
    Dr Khouri serves as Director of the Glaucoma Division and Director of Resident Education.
  • Researchgate

    Research, publications and collaborations

    The Academic Glaucoma Practice of New Jersey

    The Academic Glaucoma Practice of New Jersey

Education & Training

  • Rutgers-NJMSResidency, 2011
  • U Louisville SOMFellowship, 2011
  • St Peter's Medical CenterInternship, Internal Medicine Preliminary Year, 2007 - 2008
  • UMDNJ- New Jersey Medical SchoolFellow, Glaucoma Clinical Research, 2004 - 2007
  • American University of Beirut Faculty of MedicineClass of 1992

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2011 - 2021
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Appreciation Award American Glaucoma Society, 2020
  • Secretariat Award American Academy of Ophthalmology, 2020
  • NJ Top Doctors NJ Top Doctors, 2017-2020
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Treating glaucoma in the age of migs and laser  
    Christopher Kent, Review of Ophthalmology, 4/1/2021
  • Transforming the glaucoma treatment paradigm: sustained release drug delivery  
    Khelly Shah, Ophthalmology Management, 3/2021
  • Novel glaucoma medications: from clinical trials to clinical experience  
    V Bekerman, A Khouri, Glaucoma Today, 1/2021
  • Join now to see all

Abstracts/Posters

  • Once-daily netarsudil 0.02% vs twice-daily timolol maleate 0.5% in ocular hypertension or open-angle glaucoma, the ROCKET-4 study
    Albert Khouri, MD, Newark, NJ Jason Bacharach, MD, North Bay Eye Associates, Inc., Petaluma, CA, United States Richard A. Lewis, MD, Sacramento Eye Consultants, Sacram..., American Glaucoma Society, New York, NY, 3/3/2018
  • Scleral graft melt post tube shunt surgery: grading and identification of risk factors
    Xia T, Uppuluri A, Khouri P, NJ Glaucoma Study Group, American Glaucoma Society, NY, NY, 3/3/2018
  • Discrepancy between optical and ultrasound central corneal thickness in Glaucoma patients
    Mendez N, Chandrasekaran S, Szirth B, Khouri A., American Glaucoma Society, NY, NY, 3/2/2018

Lectures

  • Tele-Glaucoma: Mentoring for Advancement of Physician Scientists 
    American Glaucoma Society - 3/3/2018
  • Promoting Autonomy in Resident Surgical Education 
    Association of University Professors of Ophthalmology - 1/25/2018

Other

Authored Content

  • Pathways to PracticeOctober 2020
  • Overview of new glaucoma medicationsMay 2020
  • New Pharmacotherapeutics for the Treatment of Glaucoma: Targeting the Trabecular MeshworkOctober 2019
  • Highlights of the 2019 AGS annual meetingJune 2019
  • The promise of teleglaucomaMarch 2019
  • Case presentations in medical glaucomaDecember 2018
  • Join now to see all

Press Mentions

  • Netarsudil Lowers IOP in Glaucoma, Ocular Hypertension
    Netarsudil Lowers IOP in Glaucoma, Ocular HypertensionAugust 30th, 2019
  • Once-Daily Netarsudil Noninferior to Twice-Daily Timolol in Phase 3 Study
    Once-Daily Netarsudil Noninferior to Twice-Daily Timolol in Phase 3 StudyAugust 21st, 2019
  • Distributed with Glaucoma Today and CollaborativeEYE
    Distributed with Glaucoma Today and CollaborativeEYEDecember 23rd, 2018
  • Join now to see all

Grant Support

  • Bimatoprost Slow Release ImplantAllergan2013–2020
  • Artificial Intelligence and Robotic Assisted Tele-Ophthalmology in the Detection of Eye DiseaseNew Jersey Health Foundation2018–2019
  • Telemedicine for GlaucomaNew Jersey Health Foundation2014–2019
  • Analysis of MIGS outcomesNew World Medical2017–2018
  • Tele-Glaucoma feasibility and applications in patient careFund for the New Jersey Blind2017–2018

Committees

  • Subspecialty program committee, American Glaucoma Society 2018 - Present
  • Wet lab committee, World Glaucoma Association 2015 - Present
  • Rutgers New Jersey Medical School, Graduate Medical Education 2013 - Present
  • Member, New Jersey Academy of Ophthalmology 2011 - Present

Research History

  • Medical Director of Tele-OphthalmologyTele-Glaucoma Laboratory Glaucoma Imaging and Clinical Trial Research Lab2011 - Present

Professional Memberships

  • Member
  • Association for Research in Vision and Ophthalmology
    Member
  • American Glaucoma Society
    Member
  • Association of University Professors of Ophthalmology
    Member
  • International Society for Glaucoma Surgery
    Member
  • New Jersey Academy of Ophthalmology
    Member

Hospital Affiliations